{"id":999,"date":"2025-09-23T11:28:33","date_gmt":"2025-09-23T09:28:33","guid":{"rendered":"https:\/\/lensounds.com\/2025\/09\/23\/atonco-veut-revolutionner-le-traitement-du-cancer-de-la-vessie\/"},"modified":"2026-03-05T16:35:06","modified_gmt":"2026-03-05T15:35:06","slug":"atonco-aims-to-revolutionize-bladder-cancer-treatment","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/","title":{"rendered":"ATONCO AIMS TO REVOLUTIONIZE BLADDER CANCER TREATMENT"},"content":{"rendered":"

Les Echos<\/strong> \u2013 SME-Regions \/ Innovators
September 2025<\/p>\n

In early 2026, Atonco plans to launch a clinical trial for its drug candidate ATO-101, which could revolutionize the treatment of bladder cancer. The Nantes-based company, founded in 2021, is preparing to submit its application to the ANSM (French National Agency for the Safety of Medicines and Health Products) and has just raised \u20ac4 million to fund this new stage, bringing total fundraising since its inception to \u20ac10 million.<\/p>\n

Reference<\/h3>\n

Source:<\/strong> Les Echos, SME-Regions \/ Innovators<\/p>\n

Date:<\/strong> September 2025<\/p>\n

Link to original article:<\/strong> www.lesechos.fr<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Les Echos \u2013 SME-Regions \/ InnovatorsSeptember 2025 In early 2026, Atonco plans to launch a clinical trial for its drug candidate ATO-101, which could revolutionize the treatment of bladder cancer. The Nantes-based company, founded in 2021, is preparing to submit its application to the ANSM (French National Agency for the Safety of Medicines and Health […]<\/p>\n","protected":false},"author":1,"featured_media":1001,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[47],"tags":[],"class_list":["post-999","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-news"],"yoast_head":"\nAtonco Aims to Revolutionize Bladder Cancer Treatment with ATO-101<\/title>\n<meta name=\"description\" content=\"Atonco unveils groundbreaking ATO-101 clinical trial plans to revolutionize bladder cancer treatment with targeted alpha therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atonco Aims to Revolutionize Bladder Cancer Treatment with ATO-101\" \/>\n<meta property=\"og:description\" content=\"Atonco unveils groundbreaking ATO-101 clinical trial plans to revolutionize bladder cancer treatment with targeted alpha therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-23T09:28:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-05T15:35:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/les-echos.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"410\" \/>\n\t<meta property=\"og:image:height\" content=\"240\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin27\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin27\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/\"},\"author\":{\"name\":\"admin27\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"headline\":\"ATONCO AIMS TO REVOLUTIONIZE BLADDER CANCER TREATMENT\",\"datePublished\":\"2025-09-23T09:28:33+00:00\",\"dateModified\":\"2026-03-05T15:35:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/\"},\"wordCount\":91,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/les-echos.jpg\",\"articleSection\":[\"Other news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/\",\"name\":\"Atonco Aims to Revolutionize Bladder Cancer Treatment with ATO-101\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/les-echos.jpg\",\"datePublished\":\"2025-09-23T09:28:33+00:00\",\"dateModified\":\"2026-03-05T15:35:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"description\":\"Atonco unveils groundbreaking ATO-101 clinical trial plans to revolutionize bladder cancer treatment with targeted alpha therapy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/les-echos.jpg\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/les-echos.jpg\",\"width\":410,\"height\":240},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2025\\\/09\\\/23\\\/atonco-aims-to-revolutionize-bladder-cancer-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATONCO AIMS TO REVOLUTIONIZE BLADDER CANCER TREATMENT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\",\"name\":\"admin27\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"caption\":\"admin27\"},\"sameAs\":[\"https:\\\/\\\/pulsheart-medical.com\"],\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/admin27\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atonco Aims to Revolutionize Bladder Cancer Treatment with ATO-101","description":"Atonco unveils groundbreaking ATO-101 clinical trial plans to revolutionize bladder cancer treatment with targeted alpha therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Atonco Aims to Revolutionize Bladder Cancer Treatment with ATO-101","og_description":"Atonco unveils groundbreaking ATO-101 clinical trial plans to revolutionize bladder cancer treatment with targeted alpha therapy.","og_url":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/","og_site_name":"Atonco","article_published_time":"2025-09-23T09:28:33+00:00","article_modified_time":"2026-03-05T15:35:06+00:00","og_image":[{"width":410,"height":240,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/les-echos.jpg","type":"image\/jpeg"}],"author":"admin27","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin27","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/"},"author":{"name":"admin27","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"headline":"ATONCO AIMS TO REVOLUTIONIZE BLADDER CANCER TREATMENT","datePublished":"2025-09-23T09:28:33+00:00","dateModified":"2026-03-05T15:35:06+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/"},"wordCount":91,"commentCount":0,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/les-echos.jpg","articleSection":["Other news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/","url":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/","name":"Atonco Aims to Revolutionize Bladder Cancer Treatment with ATO-101","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/les-echos.jpg","datePublished":"2025-09-23T09:28:33+00:00","dateModified":"2026-03-05T15:35:06+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"description":"Atonco unveils groundbreaking ATO-101 clinical trial plans to revolutionize bladder cancer treatment with targeted alpha therapy.","breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/les-echos.jpg","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/07\/les-echos.jpg","width":410,"height":240},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2025\/09\/23\/atonco-aims-to-revolutionize-bladder-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"ATONCO AIMS TO REVOLUTIONIZE BLADDER CANCER TREATMENT"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5","name":"admin27","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","caption":"admin27"},"sameAs":["https:\/\/pulsheart-medical.com"],"url":"https:\/\/atonco-pharma.com\/en\/author\/admin27\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=999"}],"version-history":[{"count":2,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/999\/revisions"}],"predecessor-version":[{"id":1006,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/999\/revisions\/1006"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1001"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}